Opera America Magazine: 'Blind Injustice' among change agents
The world premiere opera ‘Blind Injustice,’ which tells the true stories of six exonerees freed by UC’s Ohio Innocence Project, is spotlighted by Opera America Magazine
“Blind Injustice,” a collaboration between the Ohio Innocence Project at the University of Cincinnati College of Law, Cincinnati Opera and the Young Professionals Choral Collective, is featured in the fall 2019 issue of Opera America Magazine. The production, which debuted this summer at Cincinnati Music Hall, features the true stories of six exonerees freed by the work of the OIP. Opera America Magazine spotlights the production’s themes of inequity and black Americans’ struggle for social justice, and quotes the opera’s director, Robin Guarino, an opera professor at UC’s College-Conservatory of Music.
Read the story here.
Featured image at top: Rickey Johnson (at center) in “Blind Injustice” (photo: Philip Groshong)
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.